Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     Global Drug Delivery Devices Market    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

North American Drug Delivery Devices Market Research Report

  • Report Code: DR 1001
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The North American Drug Delivery Devices Market was valued at $16 billion in 2013 and expected to be $110 billion by 2018, growing at a CAGR of 8.9%. The Oral Delivery devices market is the fastest growing segment of North American Drug Delivery Devices Market.

 

The report “North American Drug Delivery Devices Market Forecast, 2012-2018“analyzes the market of Drug Delivery Devices by 9 technologies such as oral, transdermal, respiratory, injectable, implantable, transmucosal, nasal, ocular and topical drug delivery devices. Oral drug delivery dominates the market as it is the most convenient route of administration and controlled release, a sub-segment, is a traditional, easy to adopt technology, with minimum manufacturing settings. In addition, the demand and use of orodispersible tablets (ODT) is on a rise for pediatric and geriatric patients. These factors have contributed to the large size of the oral drug delivery technology market.

 

In North America (US and Canada), the key drivers of this market is robust pharmaceutical industry, large number of pharmaceutical companies and drug delivery technology providers, and increasing number of collaborations and partnerships between technology providers and pharmaceutical companies. Due to certain amount of saturation in the market, North America is expected to grow a slower speed.

 

The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in this market and extensively covered in this report are 3M Drug Delivery Systems (U.S.), Catalent Pharma Solutions (U.S.), Becton, Dickinson and Company (U.S.), Endo Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), and Valeant Pharmaceuticals (Canada). Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.

 

Customization Options:

 

With Market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (Segment wise)
  • Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
  • Applications of the products (Segment wise and Country wise)
  • Comprehensive coverage of Product approvals, Pipeline products and Product recalls

 

Epidemiology Data

  • Country specific Prevalence of chronic diseases
  • Country specific Patient pool of chronic disease population
  • Disease progression (Pattern analysis)

 

Surgeons/Physicians Perception Analysis

  • Fast turn-around analysis of Surgeons response to market events and trends
  • Pattern analysis of usage of therapy devices wound care products by Physicians
  • Surgeons opinion about products from different companies
  • Surgeons qualitative inputs on epidemiology data

 

Brand/Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

 

Pricing Trend

  • Cost analysis of products in various countries.


1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
 

2 Executive Summary
 

3 Market Overview
 

4 Drug Delivery Devices-North America, by Segments
4.1 Injectables Drug Delivery devices-North America
4.1.1 Injectables Drug Delivery devices-North America, by Companies
4.1.1.1 Injectables Drug Delivery devices-Becton Dickinson & Company-North America
4.1.1.2 Injectables Drug Delivery devices-Gerresheimer AG-North America
4.1.1.3 Injectables Drug Delivery devices-Schott AG-North America
4.1.1.4 Injectables Drug Delivery devices-Meadwestvaco Corporation-North America
4.1.1.5 Injectables Drug Delivery devices-Amcor Limited-North America
4.1.1.6 Injectables Drug Delivery devices-AptarGroup, Inc.-North America

Please fill in the form below to receive a free copy of the Summary of this Report
















North American Drug Delivery Devices Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Brazil Medical Devices Brazil Medical Devices
Peers of Brazil medical devices are Orthopedic Devices, Ophthalmology devices, Endoscopy and Neurology Devices comprising 12.8%, 9.2%, 7.2% and 1.9% respectively of the Global Medical Devices market. It is segmented on basis of endusers and...
Nov 2015
of items
reports | Show
Connect With Us
US/CAN : +1-888-502-0539